Title | Biodegradability and toxicity of monorhamnolipid biosurfactant diastereomers. |
Publication Type | Journal Article |
Year of Publication | 2019 |
Authors | Hogan, DE, Tian, F, Malm, SW, Olivares, CI, Pacheco, RPalos, Simonich, SLMassey, Hunjan, AS, Tanguay, RL, Klimecki, WT, Polt, R, Pemberton, JE, Curry, JE, Maier, RM |
Journal | J Hazard Mater |
Volume | 364 |
Pagination | 600-607 |
Date Published | 2019 Feb 15 |
ISSN | 1873-3336 |
Abstract | Synthetic monorhamnolipids differ from biologically produced material because they are produced as single congeners, depending on the β-hydroxyalkanoic acid used during synthesis. Each congener is produced as one of four possible diastereomers resulting from two chiral centers at the carbinols of the lipid tails [(R,R), (R,S), (S,R) and (S,S)]. We compare the biodegradability (CO respirometry), acute toxicity (Microtox assay), embryo toxicity (Zebrafish assay), and cytotoxicity (xCELLigence and MTS assays) of synthetic rhamnosyl-β-hydroxydecanoyl-β-hydroxydecanoate (Rha-C10-C10) monorhamnolipids against biosynthesized monorhamnolipid mixtures (bio-mRL). All Rha-C10-C10 diastereomers and bio-mRL were inherently biodegradable ranging from 34 to 92% mineralized. The Microtox assay showed all Rha-C10-C10 diastereomers and bio-mRL are slightly toxic according to the US EPA ecotoxicity categories with 5 min EC values ranging from 39.6 to 87.5 μM. The zebrafish assay showed that of 22 developmental endpoints tested, only mortality was observed at 120 h post fertilization; all Rha-C10-C10 diastereomers and bio-mRL caused significant mortality at 640 μM, except the Rha-C10-C10 (R,R) which showed no developmental effects. xCELLigence and MTS showed IC values ranging from 103.4 to 191.1 μM for human lung cell line H1299 after 72 h exposure. These data provide key information regarding Rha-C10-C10 diastereomers that is pertinent when considering potential applications. |
DOI | 10.1016/j.jhazmat.2018.10.050 |
Alternate Journal | J. Hazard. Mater. |
PubMed ID | 30390580 |
PubMed Central ID | PMC6289288 |
Grant List | P42 ES004940 / ES / NIEHS NIH HHS / United States T32 ES007091 / ES / NIEHS NIH HHS / United States |